ArticleThe Australian and New Zealand journal of psychiatry2026
Uptake, utilisation and costs of treatment through Better Access from 2018 to 2022: An analysis of Medicare Benefits Schedule data.
Article in The Australian and New Zealand journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Australian Digital Mental Health Services for Anxiety and Depression: Meta-Analysis and Comparison Study.JMIR formative research · 2026Pooled it
- Credibility and expectancy associated with ultra-brief and standard-length digital treatments: A preliminary examination of impact on treatment outcome.The British journal of clinical psychology · 2026Trial
- Who uses Better Access treatment services? A re-analysis of data from the usual care arms of two randomised controlled trials.The Australian and New Zealand journal of psychiatry · 2026Article
- Accessibility and responsiveness of Better Access treatment services: Insights from the use of linked administrative data in the evaluation of Better Access.The Australian and New Zealand journal of psychiatry · 2026Article
- Examining the effectiveness of the Better Access initiative using data from real-world practice settings.The Australian and New Zealand journal of psychiatry · 2026Article
- Evaluation of Australia's Better Access initiative: An overview.The Australian and New Zealand journal of psychiatry · 2026Review
- Australia's Better Access initiative: A survey of provider and referrer views.The Australian and New Zealand journal of psychiatry · 2026Article
- A virtual consultative forum on future reforms to Better Access.The Australian and New Zealand journal of psychiatry · 2026Article
- Consumers' experiences with and outcomes from Better Access: Results from a national survey.The Australian and New Zealand journal of psychiatry · 2026Article
- Examining Better Access use by Australian adults using data from two longitudinal studies (Ten to Men and the Australian Longitudinal Study on Women's Health).The Australian and New Zealand journal of psychiatry · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveAustralia's Better Access initiative enables Australians with mental disorders to receive sessions of evidence-based psychological treatment following referral from an eligible provider (usually a general practitioner), subsidised through Medicare. As part of a commissioned evaluation, we examined patterns of Better Access treatment.
methodsWe sourced aggregated Medicare Benefits Schedule data from Services Australia on Better Access services delivered from 1 January 2018 to 30 June 2022. From this, we developed profiles of Better Access treatment over time and according to key consumer characteristics.
resultsIn 2021, over 1.3 million Australians received at least one treatment session subsidised through Better Access (up by 0.9% per year since 2018). People living in medium/high socioeconomic status areas within major cities, females and young adults were more likely to receive Better Access treatment compared to other groups. Consumers made an out-of-pocket payment for two-thirds (64.8%) of treatment sessions in 2021 (vs 52.7% in 2018). The median out-of-pocket payment per session was constant between 2018 and 2021 ($74) but increased to $90 in the first half of 2022. In 2021, 29.9% of fees charged for all treatment sessions nationally came from consumer out-of-pocket payments (vs 24.5% in 2018). Fewer people accessed treatment following referral in 2021 than in 2018 (58.8% vs 66.9%), and those who did waited longer until their first session (median 22 days in 2021 vs 18 days in 2018).
conclusionBetter Access enables many Australians to receive psychological treatment. Efforts are required to address gaps in access and increased wait time and consumer costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.